van Swieten JC, Caplan LR. Binswanger's disease. In: Pullicino P, Caplan LR, Hommel M, eds. Cerebral small artery disease. New York: Raven Press, 1993:193-211.

Google Scholar

Binswanger O. Die abgrenzung der allgemeinen progressiven paralyse. Klin Wochenschr 1894;49:1103-1105, 1895;50:1137-1139; and 1895;52:1180-1186.

Google Scholar

Blass JP, Hoyer S, Nitsch R. A translation of Otto Binswanger's article, 'The delineation of the generalized progressive paralyses.' Arch Neurol 1991;48:961-972.

Google Scholar

Alzheimer A. Die Seelenstorungen auf arteriosklerotischer grundlage. Z Psycht 1902;59:695-711.

Google Scholar

Olszewski J. Subcortical arteriosclerotic encephalopathy: review of the literature on the so-called Binswanger's disease and presentation of two cases. World Neurol 1965;3:359-373.

Google Scholar

Alzheimer A. Neue arbeiten uber die dementia senilis und die auf atheromatoser gefasserkrankung basierenden gehirnerkrankungen. Monatsschr Psych Neurol 1898;3:101-115.

Crossref

Google Scholar

10.

Nissl F. Zur kasuistic der arterioskleriotischen demenz: ein fall von sogenannten "encephalitis subcorticalis". Z Neurol Psychiatr 1920;19:438-443.

Google Scholar

11.

Ostrow PT, Miller LL. Pathology of small artery disease. In: Pullicino P, Caplan LR, Hommel M, eds. Cerebral small artery disease. New York: Raven Press, 1993:93-123.

Google Scholar

12.

Dubas F, Gray F, Roullet E, Escourolle R. Leucoencephalopathies arteriopathiques. Rev Neurol (Paris) 1985;141:93-108.

Google Scholar

13.

Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic amyloid angiopathy. Ann Neurol 1985;18:54-59.

Google Scholar

14.

Bogucki A, Papierz W, Szymanska R, Staniaszcyk R. Cerebral amyloid angiopathy with attenuation of the white matter on CT scans: subcortical arteriosclerotic encephalopathy (Binswanger) in a normotensive patient. J Neurol 1988;235:435-437.

Google Scholar

15.

Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser M-G. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke 1993;24:122-125.

Crossref

PubMed

Google Scholar

16.

Tournier-Lasserve E, Iba-Zizen I-T, Romero N, Bousser M-G. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991;22:1297-1302.

Crossref

PubMed

Google Scholar

17.

Mas JL, Dilouya A, de Recondo J. A familial disorder with subcortical ischemic strokes, dementia, and leukoencephalopathy. Neurology 1992;42:1015-1019.

Crossref

Google Scholar

18.

Nichols FT, Mohr JP. Binswanger's subacute arteriosclerotic encephalopathy. In: Barnett HJ, Mohr JP, Stein BM, Yatsu F, eds. Stroke, pathophysiology, diagnosis, and management, 1st ed. New York: Churchill Livingstone, 1986: 875-885.

Google Scholar

19.

Caplan LR. Binswanger's disease. In: Handbook of clinical neurology, vol 46: neurobehavioral disorders. New York: Elsevier, 1985:317-321.

Google Scholar

20.

Rosenberg GA, Kornfeld M, Stovring J, Bicknell JM. Subcortical arteriosclerotic encephalopathy (Binswanger): computerized tomography. Neurology 1979;29:1102-1106.

Crossref

PubMed

Google Scholar

21.

Zeumer H, Schonsky B, Sturn KW. Predominant white matter involvement in subcortical arteriosclerotic encephalopathy (Binswanger disease). J Comput Assist Tomogr 1980;4:14-19.

PubMed

Google Scholar

22.

Kinkel WR, Jacobs L, Polachini I, et al. Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Arch Neurol 1985;42:951-959.

Crossref

Google Scholar

23.

Kertesz A, Black SE, Tokar G, et al. Periventricular and subcortical hyperintensities on magnetic resonance imaging. Arch Neurol 1988;45:404-408.

Google Scholar

24.

Awad IA, Spetzler RF, Hodak JA, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986;17:1084-1089.

Crossref

PubMed

Google Scholar

25.

Awad IA, Johnson PC, Spetzler RF, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological findings. Stroke 1986;17:1090-1097.

Crossref

PubMed

Google Scholar

26.

Caplan LR. Binswanger's disease. Curr Opin Neurol Neurosurg 1988;1:57-62.

Google Scholar

27.

Morgello S, Farrar JT, Heier LA. Periventricular hyperintense lesions on magnetic resonance scans (abstract). Neurology 1988;38(suppl 1):139.

Google Scholar

28.

van Swieten JC, van den Hout JH, van Ketel BA, et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. Brain 1991;114:761-774.

Google Scholar

29.

Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21-23.

Google Scholar

30.

van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT or MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080-1083.

Crossref

Google Scholar

31.

Biemond A. On Binswanger's subcortical arteriosclerotic encephalopathy and the possibility of its clinical recognition. Psychiat Neurol Neurochir 1970;73:413-417.

Google Scholar

32.

Goto K, Ishii N, Fukasawa H. Diffuse white matter disease in the geriatric population: a clinical, neuropathological and CT study. Radiology 1981;141:678-695.

Google Scholar

33.

Loizou LA, Jefferson JM, Smith WT. Subcortical arteriosclerotic encephalopathy (Binswanger's type) and cortical infarcts in a young normotensive patient. J Neurol Neurosurg Psychiatry 1982;45:409-417.

Google Scholar

34.

Amico L, Caplan LR, Thomas C. Cerebrovascular complications of mucinous cancers. Neurology 1989;39:522-526.

Google Scholar

35.

DeWitt LD, Louis DN. Case records of the Massachusetts General Hospital, case 27-1991. N Engl J Med 1991;325:42-54.

Google Scholar

36.

Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the first international workshop on CADASIL, Paris, May 19-21, 1993. Stroke 1994;25:704-707.

Google Scholar

37.

Tournier-Lasserve E, Joutel A, Melski J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993;3:256-259.

Google Scholar

38.

Mayer S, Tatemichi TK, Spitz J, et al. Recurrent ischemic events and diffuse white matter disease in patients with pseudoxanthoma elasticum. Cerebrovasc Disord 1994;4:294-297.

Google Scholar

39.

Fasshauer K, Reimers CD, Gnau HJ, et al. Neurological complications of Gronblad-Strandberg syndrome. J Neurol 1984;231:250-252.

Google Scholar

40.

Messis CP, Budzilovich GN. Pseudoxanthoma elasticum: report of an autopsied case with cerebral involvement. Neurology 1970;20:703-709.

Google Scholar

41.

Pessin MS, Chung C-S. Eales disease and Groenblad-Strandberg disease (pseudoxanthoma elasticum). In: Bogousslavsky J, Caplan LR, eds. Stroke syndromes. New York: Cambridge University Press (in press).

Google Scholar

42.

Schneider R, Ringelstein EB, Zeumer H, et al. The role of plasma hyperviscosity in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol 1987;234:67-73.

Google Scholar

43.

Chung C-S, Caplan LR, van Swieten J, et al. White matter changes in stroke and fibrinogen levels (abstract). Ann Neurol 1993;34:260.

Google Scholar

44.

Grotta J, Ackerman R, Correia J. Whole blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296-301.

Google Scholar

45.

Thomas D, du Boulay G, Marshall J, et al. Effect of hematocrit on cerebral blood flow in man. Lancet 1977;2:941-943.

Google Scholar

46.

Grotta J, Ostrow P, Fraifield B, et al. Fibrinogen, blood viscosity, and cerebral ischemia. Stroke 1985;16:192-198.

Crossref

PubMed

Google Scholar

47.

Coull BM, Beamer NB, de Garmo P, et al. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attacks, and risk factors for stroke. Stroke 1991;22:162-168.

Crossref

PubMed

Google Scholar

48.

Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.

Google Scholar

49.

Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. Ther Pharm Stud 1990;11:444-451.

Google Scholar

50.

Quizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ 1991;303:605-609.

Crossref

Google Scholar

51.

Hossman V, Heiss WD, Bewermeyer H, Wiedemann G. Controlled trial of ancrod in ischemic stroke. Arch Neurol 1983;40:803-808.

Crossref

Google Scholar

52.

Waltzl M, Lechner H, Waltzl B, Schied G. Improved neurologic recovery of cerebral infarction after plasmapheretic reduction of lipids and fibrinogen. Stroke 1993;24:1447-1451.

Crossref

PubMed

Google Scholar

53.

Waltzl M. Effect of heparin-induced extracorporeal low-density lipoprotein precipitation and bezafibrate on hemorrheology and clinical symptoms in cerebral multi-infarct disease. Haemostasis 1993;23:192-202.

Google Scholar

54.

Schuff-Werner P, Schultz E, Seydel WC, et al. Improved hemorrheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest 1989;19:30-37.

Google Scholar

55.

Lechner H, Waltzl M, Waltzl B. Haemorrheological update under consideration of the HELP-system. Rev Neurol Arg 1994;19(suppl I):35-39.

Google Scholar

56.

Radack K, Deck C, Huster G. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Intern Med 1989;111:757-758.

Crossref

PubMed

Google Scholar

57.

Tanahashi N, Fukuuchi Y, Tomita M, Matsuoka S, Takeda H. Ticlopidine improves the enhanced erythrocyte aggregability in patients with cerebral infarction. Stroke 1993;24:1083-1086.

Crossref

PubMed

Google Scholar

58.

Niort G, Bulgarelli A, Cassader M, et al. Effect of short term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients. Atherosclerosis 1988;71:113-119.

Crossref

PubMed

Google Scholar

Information & Authors

Information

Published In

Neurology^®

Volume 45 • Number 4 • April 1995

Pages: 626-633

PubMed: 7723946

Copyright

Publication History

Published online: April 1, 1995

Published in print: April 1995

Permissions

Request permissions for this article.

Request Permissions

Authors

Affiliations & Disclosures

Louis R. Caplan, MD

View all articles by this author

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By

- Robin A. Hurley,
- Hidekazu Tomimoto,
- Ichiro Akiguchi,
- Ronald E. Fisher,
- Katherine H. Taber,
- Katherine H. Taber,
Chapter 19. Binswanger’s Disease: An Ongoing Controversy, Windows to the Brain: Insights From Neuroimaging, (137-141), (2024).https://doi.org/10.1176/appi.books.9781615377886.lg21
Crossref
- Hannsjörg Schröder,
- Rob A. I. de Vos,
- Stefan Huggenberger,
- Lennart Müller-Thomsen,
- Annemieke Rozemuller,
- Farman Hedayat,
- Natasha Moser,
- Hannsjörg Schröder,
- Rob A.I. de Vos,
- Stefan Huggenberger,
- Lennart Müller-Thomsen,
- Annemieke Rozemuller,
- Farman Hedayat,
- Natasha Moser,
General Considerations, The Human Brainstem, (3-55), (2023).https://doi.org/10.1007/978-3-030-89980-6_1
Crossref
- Yangqiao Zeng,
- Xiaoqin Li,
- Wei Chen,
- Juan Du,
- Tao Tao,
Reversible Dementia With Bilateral White Matter Changes Caused by Dural Arteriovenous Fistula, The Neurologist, (2022).https://doi.org/10.1097/NRL.0000000000000473
Crossref
- Gary A. Rosenberg,
- Takakuni Maki,
- Ken Arai,
- Eng H. Lo,
Gliovascular Mechanisms and White Matter Injury in Vascular Cognitive Impairment and Dementia, Stroke, (153-160.e4), (2022).https://doi.org/10.1016/B978-0-323-69424-7.00013-2
Crossref
- Miaomiao Dou,
- Yan Cen,
- Jie Zhong,
- Guilin Chen,
- Qian Wei,
- Yanying Zeng,
- Xiaowei Lu,
Association between frailty index based on routine laboratory tests and risk of cerebral small vessel disease in elderly patients: a hospital-based observational study, Aging Clinical and Experimental Research, 34, 11, (2683-2692), (2022).https://doi.org/10.1007/s40520-022-02207-8
Crossref
- Bernadette Mdawar,
- Christina Abi Faraj,
- Munir Khani,
- Wael Shamseddeen,
Episode of mixed mood with psychotic features secondary to Binswanger disease: a case report with a literature review, BMJ Case Reports, 14, 3, (e238957), (2021).https://doi.org/10.1136/bcr-2020-238957
Crossref
- Jakub Litak,
- Marek Mazurek,
- Bartłomiej Kulesza,
- Paweł Szmygin,
- Joanna Litak,
- Piotr Kamieniak,
- Cezary Grochowski,
Cerebral Small Vessel Disease, International Journal of Molecular Sciences, 21, 24, (9729), (2020).https://doi.org/10.3390/ijms21249729
Crossref
- Vitalie Văcăraș,
- Adrian Mihai Cordoș,
- Imelda Rahovan,
- Sorina Frunze,
- Dafin Fior Mureșanu,
Binswanger's disease: Case presentation and differential diagnosis, Clinical Case Reports, 8, 12, (3449-3456), (2020).https://doi.org/10.1002/ccr3.3459
Crossref
- Gary A. Rosenberg,
- Jillian Prestopnik,
- Janice Knoefel,
- John C. Adair,
- Jeffrey Thompson,
- Rajikha Raja,
- Arvind Caprihan,
A Multimodal Approach to Stratification of Patients with Dementia: Selection of Mixed Dementia Patients Prior to Autopsy, Brain Sciences, 9, 8, (187), (2019).https://doi.org/10.3390/brainsci9080187
Crossref
- Yu. N. Fedulaev,
- D. D. Kaminer,
- A. Yu. Chuprakova,
- S. T. Fatullaev,
- B. D. Dmitriev,
Clinical case of progressive vascular leukophalopathia, Medical alphabet, 2, 27, (45-47), (2019).https://doi.org/10.33667/2078-5631-2019-2-27(402)-45-47
Crossref
See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login

Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
[email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

Figures

Tables

Media

Impact Factor

We are pleased to announce that Neurology^® was awarded a new Impact Factor of 8.4. Explore our latest research and articles and join our community of distinguished authors by submitting your work .

Open Review Pilot Project

Explore peer reviews, author responses, and editor comments on selected articles.

Learn More

Letters to the Editor

The Letters section represents an opportunity for ongoing author debate and post-publication peer review. View our submission guidelines for Letters to the Editor before submitting your comment.

Submit a Letter for this article

Binswanger's disease--revisited

Get full access to this article

REFERENCES